Published Date: 26 Apr 2023
Health officials have wondered how many U.S. children are being diagnosed with autism as it becomes more common. S. How many children experience more severe symptoms like a very low IQ and verbal immaturity, and how many kids have relatively mild symptoms?
Read Full NewsPatients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
1.
Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.
2.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
3.
Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
4.
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?
5.
In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.
1.
The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025
2.
A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer
3.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
4.
Unlocking the Potential of Polatuzumab for Cancer Treatment
5.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
5.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation